First test of new drug in healthy volunteers

NCT ID NCT07307274

Summary

This is the first study in humans for a new drug called SYNT-101. It aims to check the safety and how the body processes the drug in 64 healthy adults, including some who are overweight. Participants will receive either the drug or a placebo, and researchers will monitor for any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Veritus Research

    RECRUITING

    Bayswater, Victoria, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.